Sotevtamab, the novel bispecific antibody , is sparking considerable interest within the oncology community, particularly regarding its potential for managing blood cancers. The therapy works by https://lucyxwky570196.aboutyoublog.com/52962134/sotevtamab-a-new-hope-in-blood-malignancies